307
Participants
Start Date
January 24, 2013
Primary Completion Date
November 19, 2013
Study Completion Date
November 19, 2013
Evolocumab
Subcutaneous injection
Placebo to Evolocumab
Subcutaneous injection
Ezetimibe
Tablet for oral administration
Placebo to Ezetimibe
Tablet for oral administration
Research Site, Brussels
Research Site, Midrand
Research Site, Camperdown
Research Site, Ballerup Municipality
Research Site, Melbourne
Research Site, Milton
Research Site, Reinach
Research Site, Perth
Research Site, Lugano
Research Site, La Louvière
Research Site, Vejle
Research Site, Somerset West
Research Site, Observatory
Research Site, Ghent
Research Site, Aalborg
Research Site, New York
Research Site, Córdoba
Research Site, Raleigh
Research Site, Atlanta
Research Site, Atlanta
Research Site, Savannah
Research Site, Reus
Research Site, Cleveland
Research Site, Akron
Research Site, Cincinnati
Research Site, Traverse City
Research Site, Zaragoza
Research Site, Lille
Research Site, St Louis
Research Site, Heppenheim an der Bergstrasse
Research Site, Vénissieux
Research Site, Norman
Research Site, Paris
Research Site, Houston
Research Site, Bad Krozingen
Research Site, Henderson
Research Site, Las Vegas
Research Site, Las Vegas
Research Site, Los Angeles
Research Site, Thousand Oaks
Research Site, Mission Viejo
Research Site, Carmichael
Research Site, Auburn
Research Site, Newmarket
Research Site, Lachine
Research Site, Pointe-Claire
Research Site, Dresden
Research Site, Hong Kong
Research Site, New Territories
Research Site, Alkmaar
Research Site, Amsterdam
Research Site, Groningen
Research Site, Lodz
Research Site, Warsaw
Research Site, Liverpool
Research Site, London
Research Site, Telford
Research Site, West Bromwich
Lead Sponsor
Amgen
INDUSTRY